Seuba Xavier
University Pompeu Fabra, Barcelona, Spain.
Bull World Health Organ. 2006 May;84(5):405-7; discussion 408-11. doi: 10.2471/blt.04.019133. Epub 2006 May 17.
Since the first WHO Model List of Essential Medicines was adopted in 1977, it has become a popular tool among health professionals and Member States. WHO's joint effort with the United Nations Committee on Economic, Social and Cultural Rights has resulted in the inclusion of access to essential medicines in the core content of the right to health. The Committee states that the right to health contains a series of elements, such as availability, accessibility, acceptability and quality of health goods, services and programmes, which are in line with the WHO statement that essential medicines are intended to be available within the context of health systems in adequate amounts at all times, in the appropriate dosage forms, with assured quality and information, and at a price that the individual and the community can afford. The author considers another perspective by looking at the obligations to respect, protect and fulfil the right to health undertaken by the states adhering to the International Covenant of Economic, Social and Cultural Rights (ICESCR) and explores the relationship between access to medicines, the protection of intellectual property, and human rights.
自1977年世界卫生组织《基本药物标准清单》首次采用以来,它已成为卫生专业人员和会员国中流行的工具。世卫组织与联合国经济、社会及文化权利委员会的共同努力,已将获得基本药物纳入健康权的核心内容。该委员会指出,健康权包含一系列要素,如卫生商品、服务和方案的可及性、可获得性、可接受性和质量,这与世卫组织的声明一致,即基本药物旨在始终在卫生系统范围内以适当剂型、有保证的质量和信息,以及个人和社区能够承受的价格提供足够数量的药物。作者通过审视遵守《经济、社会及文化权利国际公约》(ICESCR)的国家在尊重、保护和实现健康权方面的义务,探讨了获得药物、知识产权保护与人权之间的关系,从而考虑了另一个视角。